Veklury and Lorazepam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Veklury (remdesivir) and Lorazepam (lorazepam). Common drug interactions include cerebrovascular accident among females and bradycardia among males.

The phase IV clinical study analyzes what interactions people have when they take Veklury and Lorazepam. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Veklury?

Veklury has active ingredients of remdesivir. eHealthMe is studying from 2,753 Veklury users. Check the latest studies of Veklury.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 16, 2026

15 people who take Veklury and Lorazepam together, and have interactions are studied.

Veklury and Lorazepam drug interactions.

What are the common drug interactions of Veklury and Lorazepam, by gender? *:

female:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Leukocytosis (increased white blood cells)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Arrhythmia (irregular heartbeat)
Asthenia (weakness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bradycardia (abnormally slow heart action)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Cough

male:

Bradycardia (abnormally slow heart action)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Iron deficiency
Lactic acidosis (low ph in body tissues)
Liver injury
Pneumonia
Retroperitoneal haematoma (blood clot between the peritoneum and the posterior abdominal wall)
Septic shock (shock due to blood infection)
Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
Swelling

What are the common drug interactions of Veklury and Lorazepam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Leukocytosis (increased white blood cells)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

20-29:

n/a

30-39:

n/a

40-49:

Bradycardia (abnormally slow heart action)

50-59:

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Renal impairment (severely reduced kidney function)
Bradycardia (abnormally slow heart action)
Cytokine storm (over-protective immune response that can actually be fatal)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Haemoglobin decreased
Hyperglycaemia (high blood sugar)
Hyperkalaemia (damage to or disease of the kidney)
Hypotension (abnormally low blood pressure)
Iron deficiency

60+:

Bradycardia (abnormally slow heart action)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Dyspnoea (difficult or laboured respiration)
Hepatic enzyme increased
Hepatotoxicity (chemical-driven liver damage)
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
Pyrexia (fever)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)

What are the existing conditions these people have? *

Urination - Excessive Volume: 1 person, 6.67%
Nausea And Vomiting: 1 person, 6.67%
Hypokalemia (low potassium): 1 person, 6.67%
Hyperammonaemia: 1 person, 6.67%
High Blood Pressure: 1 person, 6.67%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 1 person, 6.67%
Gastric Ulcer (stomach ulcer): 1 person, 6.67%
Alcohol Withdrawal Syndrome: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Veklury and Lorazepam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously